These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9669206)

  • 1. Inhibition of leukotriene B4-induced increase in intracellular calcium ion level of human peripheral blood polymorphonuclear leukocytes by Y-24180, an antagonist of platelet-activating factor receptor.
    Komatsu H; Amano M
    Int J Immunopharmacol; 1997; 19(11-12):661-7. PubMed ID: 9669206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between synthesis of platelet-activating factor and leukotriene B4 in isolated human polymorphonuclear leukocytes.
    Moilanen E; Kirkkola AL; Kankaanranta H; Nieminen MM; Vapaatalo H
    Inflammation; 1993 Dec; 17(6):705-14. PubMed ID: 8112829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of activation of human peripheral blood eosinophils by Y-24180, an antagonist to platelet-activating factor receptor.
    Komatsu H; Amano M; Yamaguchi S; Sugahara K
    Life Sci; 1999; 65(13):PL171-6. PubMed ID: 10503965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.
    Koike H; Imanishi N; Natsume Y; Morooka S
    Eur J Pharmacol; 1994 Nov; 269(3):299-309. PubMed ID: 7895770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
    Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
    Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of leukocyte adhesion to endothelial cells of human umbilical vein by Y-24180, an antagonist of platelet-activating factor.
    Komatsu H; Nagasawa M; Okumoto T
    Int J Immunopharmacol; 1993 Aug; 15(6):737-44. PubMed ID: 7691768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediation by platelet-activating factor of 12-hydroxyeicosatetraenoic acid-induced cytosolic free calcium concentration elevation in neutrophils.
    Shibata K; Yoshino H; Mizuno N; Shinohara H; Morita K; Kitayama S; Kurihara H; Dohi T
    Prostaglandins Other Lipid Mediat; 2000 Oct; 62(4):385-94. PubMed ID: 11060901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart.
    Hu W; McNicholl IK; Choy PC; Man RY
    Br J Pharmacol; 1993 Oct; 110(2):645-50. PubMed ID: 8242237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of cytosolic calcium ion concentrations in human endothelial cells in response to thrombin, platelet-activating factor, and leukotriene B4.
    Lerner R
    J Lab Clin Med; 1994 Nov; 124(5):723-9. PubMed ID: 7964131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
    Sanz MJ; Weg VB; Walsh DT; Williams TJ; Nourshargh S
    Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 13-HODE inhibits the intracellular calcium increase of activated human polymorphonuclear cells.
    van de Velde MJ; Engels F; Henricks PA; Nijkamp FP
    J Leukoc Biol; 1994 Aug; 56(2):200-2. PubMed ID: 8071595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired surface expression of PAF receptors on human neutrophils is dependent upon cell activation.
    Zhou W; Javors MA; Olson MS
    Arch Biochem Biophys; 1994 Feb; 308(2):439-45. PubMed ID: 8109973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenteric microvascular inflammatory responses to systemic hypoxia are mediated by PAF and LTB4.
    Casillan AJ; Gonzalez NC; Johnson JS; Steiner DR; Wood JG
    J Appl Physiol (1985); 2003 Jun; 94(6):2313-22. PubMed ID: 12598480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotactic peptide down-regulation of calcium mobilization induced by platelet-activating factor and by leukotriene B4 in human neutrophils is uncovered by protein phosphatase inhibitors.
    Montero M; Garcia-Sancho J; Alverez J
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):559-66. PubMed ID: 7980418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
    Floch A; Tahraoui L; Sedivy P; Cavero I
    J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAF-mediated platelet adhesion to endothelial cells induced by FMLP-stimulated leukocytes.
    Hirafuji M; Shinoda H
    J Lipid Mediat; 1991 Nov; 4(3):347-51. PubMed ID: 1662550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor induced calcium mobilization and phosphoinositide metabolism in cultured bovine cerebral microvascular endothelial cells.
    Lin AY; Rui YC
    Biochim Biophys Acta; 1994 Nov; 1224(2):323-8. PubMed ID: 7981248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement by staurosporine of platelet-activating factor formation in N-formyl peptide-challenged human neutrophils is mediated by intracellular platelet-activating factor binding sites.
    Müller S; Nigam S
    Biochem Biophys Res Commun; 1992 Dec; 189(2):771-6. PubMed ID: 1335246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a platelet-activating factor antagonist, WEB 2086, on inhibition of active oxygen generation in human polymorphonuclear leukocytes.
    Suzuki S; Sugai K; Sato H; Arakawa M
    Pharmacology; 1994 Feb; 48(2):111-8. PubMed ID: 8134402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.